Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gale

Showing results (341-350 of 359) with videos related to

Pageof 36
Sort By:
Elife|August 3, 2021
Endomembrane targeting of human OAS1 p46 augments antiviral activityFrank W Soveg, Johannes Schwerk, Nandan S Gokhale, et al.
Nature Communications|July 19, 2024
Cytomegalovirus vaccine vector-induced effector memory CD4 + T cells protect cynomolgus macaques from lethal aerosolized heterologous avian influenza challengeDaniel Malouli, Meenakshi Tiwary, Roxanne M Gilbride, et al.
Journal of Medicinal Chemistry|August 19, 2023
Discovery of GS-5245 (Obeldesivir), an Oral Prodrug of Nucleoside GS-441524 That Exhibits Antiviral Efficacy in SARS-CoV-2-Infected African Green MonkeysRichard L Mackman, Rao V Kalla, Darius Babusis, et al.
Plos Pathogens|March 13, 2020
Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisitionGiacomo Gorini, Slim Fourati, Monica Vaccari, et al.
Cell Host & Microbe|August 18, 2022
Cytomegalovirus-vaccine-induced unconventional T cell priming and control of SIV replication is conserved between primate speciesDaniel Malouli, Roxanne M Gilbride, Helen L Wu, et al.
Critical Care Explorations|January 5, 2023
Angiopoietin-Like4 Is a Novel Marker of COVID-19 SeverityPavan K Bhatraju, Eric D Morrell, Ian B Stanaway, et al.
Nature Medicine|November 8, 2016
Fetal brain lesions after subcutaneous inoculation of Zika virus in a pregnant nonhuman primateKristina M Adams Waldorf, Jennifer E Stencel-Baerenwald, Raj P Kapur, et al.
Science (New York, N.Y.)|November 6, 2020
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2Thomas W Linsky, Renan Vergara, Nuria Codina, et al.
Plos Pathogens|July 6, 2021
Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacyFredrik Barrenäs, Scott G Hansen, Lynn Law, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2022
Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaquesTimothy N Hoang, Elise G Viox, Amit A Upadhyay, et al.
Pageof 36

Showing results (341-350 of 359) with videos related to

Sort By:
Pageof 36
Elife|August 3, 2021
Endomembrane targeting of human OAS1 p46 augments antiviral activityFrank W Soveg, Johannes Schwerk, Nandan S Gokhale, et al.
Nature Communications|July 19, 2024
Cytomegalovirus vaccine vector-induced effector memory CD4 + T cells protect cynomolgus macaques from lethal aerosolized heterologous avian influenza challengeDaniel Malouli, Meenakshi Tiwary, Roxanne M Gilbride, et al.
Journal of Medicinal Chemistry|August 19, 2023
Discovery of GS-5245 (Obeldesivir), an Oral Prodrug of Nucleoside GS-441524 That Exhibits Antiviral Efficacy in SARS-CoV-2-Infected African Green MonkeysRichard L Mackman, Rao V Kalla, Darius Babusis, et al.
Plos Pathogens|March 13, 2020
Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisitionGiacomo Gorini, Slim Fourati, Monica Vaccari, et al.
Cell Host & Microbe|August 18, 2022
Cytomegalovirus-vaccine-induced unconventional T cell priming and control of SIV replication is conserved between primate speciesDaniel Malouli, Roxanne M Gilbride, Helen L Wu, et al.
Critical Care Explorations|January 5, 2023
Angiopoietin-Like4 Is a Novel Marker of COVID-19 SeverityPavan K Bhatraju, Eric D Morrell, Ian B Stanaway, et al.
Nature Medicine|November 8, 2016
Fetal brain lesions after subcutaneous inoculation of Zika virus in a pregnant nonhuman primateKristina M Adams Waldorf, Jennifer E Stencel-Baerenwald, Raj P Kapur, et al.
Science (New York, N.Y.)|November 6, 2020
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2Thomas W Linsky, Renan Vergara, Nuria Codina, et al.
Plos Pathogens|July 6, 2021
Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacyFredrik Barrenäs, Scott G Hansen, Lynn Law, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2022
Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaquesTimothy N Hoang, Elise G Viox, Amit A Upadhyay, et al.
Pageof 36